MARK YOUR CALENDAR

Informational Session: Awards Program Supporting Diversity in Clinical Trials

Are you a medical student or physician interested in community-based clinical research? The PhRMA Foundation will host a webinar from 1-2 p.m. ET Sept. 13 about the Robert A. Winn Diversity in Clinical Trials Award Program, which supports early-stage investigator physicians and medical students of diverse backgrounds to explore pathways to become clinical trialists. Register now to learn about this program, supported by the Bristol Myers Squibb Foundation, Virginia Commonwealth University, and American Association for Cancer Research. 

Networking Reception: AAPS' PharmSci Meeting

If you are attending the American Association of Pharmaceutical Scientists (AAPS) meeting in October or live in the Boston area, come out to meet the PhRMA Foundation team and our latest awardees. 

IN THE NEWS

Foundations Are Bolstering Pharmacists Working to Improve Health Outcomes

PhRMA Foundation President Dr. Amy M. Miller spoke to the American Association of Colleges of Pharmacy's news magazine about our efforts to support young researchers exploring the discovery and delivery of targeted therapeutics ranging from cardiovascular medicines to cancer treatments. Read more. 

ANNUAL REPORT

Read About Our 2021 Awardees' Research

In 2021, the Foundation funded 42 researchers conducting work in drug delivery, drug discovery, translational medicine, value assessment and health outcomes research, awarding a total of $3 million. Learn more about the Foundation, its grants and fellowships, and our 2021 awardees by reading the Annual Report.

FROM OUR BLOG

Foundation-Funded Research Efforts Span the Spectrum of Alzheimer’s Disease

Through its grants and awards, the Foundation has supported scientists working at the frontiers of Alzheimer’s disease research, from identifying genetic risk factors and novel therapeutic targets to assessing the impact of health policies on quality of care for people with dementia. We asked several awardees about their work and what they hope to accomplish. Read the summary blog here or individual Q&As below.

Communicating Your Research: How to Write a Lay Summary

Communicating research to the public benefits both researchers and society, but many scientists do not have adequate opportunities to receive science communications training. In this blog, PhRMA Foundation Head of Communications Emily Ortman provides five tips for writing a lay summary, a research description that uses clear, plain language for a public audience. Read more.

Addressing Gaps in Bringing New Medicines to Patients

Molecular diagnostic testing is critical to advancing precision medicine. This means challenges facing the diagnostics industry are also challenges for the biopharmaceutical industry, PhRMA Foundation's Dr. Miller writes in a recent blog post.

PUBLICATIONS

Congrats to these Foundation-funded researchers on their recent work!

Dissecting the treatment-naive ecosystem of human melanoma brain metastasis, Cell

Albert Agustinus, Memorial Sloan Kettering Cancer Center

Approaches to Improve Macromolecule and Nanoparticle Accumulation in the Tumor Microenvironment by the Enhanced Permeability and Retention Effect, Polymers

Victor Ejigah, MS, Howard University

Studies on some neuropharmacological properties of Nevirapine in mice, IBRO Neuroscience Reports

Victor Ejigah, MS, Howard University

A touch-based multimodal and cryptographic bio-human–machine interface, PNAS

Sam Emaminejad, PhD, University of California, Los Angeles

Cost-effectiveness of population-wide genomic screening for Lynch syndrome in the United States, Genetics in Medicine

Shangqing Jiang, University of Washington

Implementation of pharmacogenomic clinical decision support for health systems: a cost-utility analysis, Pharmacogenomics

Shangqing Jiang, University of Washington

Income disparities in driving distance to health care infrastructure in the United States: a geographic information systems analysis, BMC Research Notes

Serena Jingchuan Guo, MD, PhD, University of Florida

Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional study, PLoS Medicine

Serena Jingchuan Guo, MD, PhD, University of Florida

Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies, Antiviral Research

Marwah Karim, Stanford University

A Pragmatic Guide to Assessing Real Option Value for Medical Technologies, Value in Health

Meng Li, ScM, PhD, University of Texas MD Anderson Cancer Center

Comparisons of in Vitro Models to Evaluate the Membrane Permeability of Amorphous Drug Nanoparticles, Molecular Pharmaceutics

Na Li, PhD, University of Connecticut

Mechanisms and Extent of Enhanced Passive Permeation by Colloidal Drug Particles, Molecular Pharmaceutics

Na Li, PhD, University of Connecticut

Prediction of protein-ligand binding affinity from sequencing data with interpretable machine learning, Nature Biotechnology

Xiaoting Li, Columbia University

Surface-modified nanotherapeutics targeting atherosclerosis, Biomaterials Science

Jianqin Lu, PhD, University of Arizona

Camptothesome elicits immunogenic cell death to boost colorectal cancer immune checkpoint blockade, Journal of Controlled Release

Jianqin Lu, PhD, University of Arizona

Editorial: Improvements in Hospital Adverse Event Rates, JAMA

William Padula, PhD, University of Southern California

Ionic liquids charge ahead, Nature Chemistry

Eden E. L. Tanner, DPhil, University of Mississippi

Preformulation Studies with Phenylalanine Ammonia Lyase: Essential Prelude to a Microcapsule Formulation for the Management of Phenylketonuria, Journal of Pharmaceutical Sciences

Nhu Truong, University of Maryland, Baltimore

Granzyme K+ CD8 T cells form a core population in inflamed human tissue, Science Translational Medicine

Fan Zhang, PhD, University of Colorado School of Medicine